Tugnait, M., Gupta, N., Hanley, M. J., Sonnichsen, D., Kerstein, D., Dorer, D. J., . . . Narasimhan, N. (2019). Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers. Clin Pharmacol Drug Dev.

Tugnait, Meera, Neeraj Gupta, Michael J. Hanley, Daryl Sonnichsen, David Kerstein, David J. Dorer, Karthik Venkatakrishnan, and Narayana Narasimhan. "Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction On the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.

Tugnait, Meera, et al. "Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction On the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers." Clin Pharmacol Drug Dev 2019.